These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 36689459)
1. In silico investigation of cytochrome bc1 molecular inhibition mechanism against Trypanosoma cruzi. Muscat S; Grasso G; Scapozza L; Danani A PLoS Negl Trop Dis; 2023 Jan; 17(1):e0010545. PubMed ID: 36689459 [TBL] [Abstract][Full Text] [Related]
2. Utilizing Chemical Genomics to Identify Cytochrome b as a Novel Drug Target for Chagas Disease. Khare S; Roach SL; Barnes SW; Hoepfner D; Walker JR; Chatterjee AK; Neitz RJ; Arkin MR; McNamara CW; Ballard J; Lai Y; Fu Y; Molteni V; Yeh V; McKerrow JH; Glynne RJ; Supek F PLoS Pathog; 2015 Jul; 11(7):e1005058. PubMed ID: 26186534 [TBL] [Abstract][Full Text] [Related]
3. The Q Wall RJ; Carvalho S; Milne R; Bueren-Calabuig JA; Moniz S; Cantizani-Perez J; MacLean L; Kessler A; Cotillo I; Sastry L; Manthri S; Patterson S; Zuccotto F; Thompson S; Martin J; Marco M; Miles TJ; De Rycker M; Thomas MG; Fairlamb AH; Gilbert IH; Wyllie S ACS Infect Dis; 2020 Mar; 6(3):515-528. PubMed ID: 31967783 [TBL] [Abstract][Full Text] [Related]
4. Subtle changes in endochin-like quinolone structure alter the site of inhibition within the cytochrome bc1 complex of Plasmodium falciparum. Stickles AM; de Almeida MJ; Morrisey JM; Sheridan KA; Forquer IP; Nilsen A; Winter RW; Burrows JN; Fidock DA; Vaidya AB; Riscoe MK Antimicrob Agents Chemother; 2015 Apr; 59(4):1977-82. PubMed ID: 25605352 [TBL] [Abstract][Full Text] [Related]
5. Targeted Structure-Activity Analysis of Endochin-like Quinolones Reveals Potent Qi and Qo Site Inhibitors of Toxoplasma gondii and Plasmodium falciparum Cytochrome bc McConnell EV; Bruzual I; Pou S; Winter R; Dodean RA; Smilkstein MJ; Krollenbrock A; Nilsen A; Zakharov LN; Riscoe MK; Doggett JS ACS Infect Dis; 2018 Nov; 4(11):1574-1584. PubMed ID: 30117728 [TBL] [Abstract][Full Text] [Related]
6. The cytochrome bc Dreinert A; Wolf A; Mentzel T; Meunier B; Fehr M Biochim Biophys Acta Bioenerg; 2018 Aug; 1859(8):567-576. PubMed ID: 29704498 [TBL] [Abstract][Full Text] [Related]
7. The cytochrome b lysine 329 residue is critical for ubihydroquinone oxidation and proton release at the Q Francia F; Khalfaoui-Hassani B; Lanciano P; Musiani F; Noodleman L; Venturoli G; Daldal F Biochim Biophys Acta Bioenerg; 2019 Feb; 1860(2):167-179. PubMed ID: 30550726 [TBL] [Abstract][Full Text] [Related]
8. Functional flexibility of electron flow between quinol oxidation Q Borek A; Ekiert R; Osyczka A Biochim Biophys Acta Bioenerg; 2018 Sep; 1859(9):754-761. PubMed ID: 29705394 [TBL] [Abstract][Full Text] [Related]
9. Novel N,N-di-alkylnaphthoimidazolium derivative of β-lapachone impaired Trypanosoma cruzi mitochondrial electron transport system. Bombaça ACS; Silva LA; Chaves OA; da Silva LS; Barbosa JMC; da Silva AM; Ferreira ABB; Menna-Barreto RFS Biomed Pharmacother; 2021 Mar; 135():111186. PubMed ID: 33395606 [TBL] [Abstract][Full Text] [Related]
10. Design and use of photoactive ruthenium complexes to study electron transfer within cytochrome bc1 and from cytochrome bc1 to cytochrome c. Millett F; Havens J; Rajagukguk S; Durham B Biochim Biophys Acta; 2013; 1827(11-12):1309-19. PubMed ID: 22985600 [TBL] [Abstract][Full Text] [Related]
11. The cytochrome b Zn binding amino acid residue histidine 291 is essential for ubihydroquinone oxidation at the Q Francia F; Malferrari M; Lanciano P; Steimle S; Daldal F; Venturoli G Biochim Biophys Acta; 2016 Nov; 1857(11):1796-1806. PubMed ID: 27550309 [TBL] [Abstract][Full Text] [Related]
12. Mitochondrial Disease-related Mutation G167P in Cytochrome b of Rhodobacter capsulatus Cytochrome bc1 (S151P in Human) Affects the Equilibrium Distribution of [2Fe-2S] Cluster and Generation of Superoxide. Borek A; Kuleta P; Ekiert R; Pietras R; Sarewicz M; Osyczka A J Biol Chem; 2015 Sep; 290(39):23781-92. PubMed ID: 26245902 [TBL] [Abstract][Full Text] [Related]
13. A comparative assessment of mitochondrial function in epimastigotes and bloodstream trypomastigotes of Trypanosoma cruzi. Gonçalves RL; Barreto RF; Polycarpo CR; Gadelha FR; Castro SL; Oliveira MF J Bioenerg Biomembr; 2011 Dec; 43(6):651-61. PubMed ID: 22081211 [TBL] [Abstract][Full Text] [Related]
14. Drug discovery for chagas disease: A viewpoint. Kratz JM Acta Trop; 2019 Oct; 198():105107. PubMed ID: 31351074 [TBL] [Abstract][Full Text] [Related]
15. Mitochondrial complex III defects contribute to inefficient respiration and ATP synthesis in the myocardium of Trypanosoma cruzi-infected mice. Wen JJ; Garg NJ Antioxid Redox Signal; 2010 Jan; 12(1):27-37. PubMed ID: 19624257 [TBL] [Abstract][Full Text] [Related]
16. Complexes of Trypanosoma cruzi sterol 14α-demethylase (CYP51) with two pyridine-based drug candidates for Chagas disease: structural basis for pathogen selectivity. Hargrove TY; Wawrzak Z; Alexander PW; Chaplin JH; Keenan M; Charman SA; Perez CJ; Waterman MR; Chatelain E; Lepesheva GI J Biol Chem; 2013 Nov; 288(44):31602-15. PubMed ID: 24047900 [TBL] [Abstract][Full Text] [Related]